Pharma Bio Serv, Inc. - Understand $pbsv stock

$PBSV Market Cap: $13.77 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$10.77M

TTM

Gross Margin

25.16%

TTM

Net Earnings

-$840.9K

TTM

Current Assets

$15.94M

Q3 2024

Current Liabilities

$1.899M

Q3 2024

Current Ratio

839.03%

Q3 2024

Total Assets

$16.32M

Q3 2024

Total Liabilities

$2.632M

Q3 2024

Book Value

$13.69M

Q3 2024

Cash

$6.520M

Q3 2024

P/E

-16.38

Nov 29, 2024 EST

Free Cash Flow

-$337.8K

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Revenue	$16.98M	$19.40M	$20.12M	$21.56M	$19.51M	$17.80M	$13.30M	$19.54M	$23.38M	$27.56M	$33.06M	$29.23M	$19.93M	$11.35M	$11.48M	$15.20M	$16.21M	$14.23M	$10.00K
YoY Change	-12.48%	-3.56%	-6.72%	10.55%	9.61%	33.84%	-31.94%	-16.46%	-15.15%	-16.64%	13.1%	46.66%	75.59%	-1.13%	-24.47%	-6.23%	13.91%	142200.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Revenue	$16.98M	$19.40M	$20.12M	$21.56M	$19.51M	$17.80M	$13.30M	$19.54M	$23.38M	$27.56M	$33.06M	$29.23M	$19.93M	$11.35M	$11.48M	$15.20M	$16.21M	$14.23M	$10.00K
Cost Of Revenue	$11.91M	$14.52M	$14.76M	$14.90M	$13.33M	$12.11M	$9.455M	$13.75M	$15.90M	$18.58M	$21.23M	$19.36M	$13.07M	$7.950M	$7.640M	$9.410M	$9.380M	$8.120M
Gross Profit	$5.066M	$4.881M	$5.360M	$6.667M	$6.177M	$5.687M	$3.842M	$5.783M	$7.484M	$8.970M	$11.83M	$9.870M	$6.860M	$3.390M	$3.840M	$5.790M	$6.820M	$6.110M
Gross Profit Margin	29.84%	25.16%	26.65%	30.92%	31.66%	31.95%	28.89%	29.6%	32.01%	32.55%	35.78%	33.77%	34.42%	29.87%	33.45%	38.09%	42.07%	42.94%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Selling, General & Admin	$3.949M	$3.707M	$9.214M	$4.441M	$4.480M	$4.599M	$4.660M	$5.875M	$5.703M	$6.110M	$5.760M	$4.140M	$3.410M	$2.780M	$2.920M	$3.140M	$3.180M	$2.030M	$40.00K
YoY Change	6.54%	-59.77%	107.46%	-0.87%	-2.58%	-1.32%	-20.68%	3.01%	-6.66%	6.08%	39.13%	21.41%	22.66%	-4.79%	-7.01%	-1.26%	56.65%	4975.0%
% of Gross Profit	77.94%	75.93%	171.9%	66.62%	72.53%	80.86%	121.28%	101.59%	76.2%	68.12%	48.69%	41.95%	49.71%	82.01%	76.04%	54.23%	46.63%	33.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$48.09K	$51.11K	$72.73K	$86.28K	$99.10K	$74.60K	$107.7K	$312.6K	$357.5K	$380.0K	$340.0K	$320.0K	$320.0K	$320.0K	$310.0K	$230.0K	$210.0K	$200.0K
YoY Change	-5.9%	-29.73%	-15.71%	-12.93%	32.84%	-30.72%	-65.55%	-12.56%	-5.93%	11.76%	6.25%	0.0%	0.0%	3.23%	34.78%	9.52%	5.0%
% of Gross Profit	0.95%	1.05%	1.36%	1.29%	1.6%	1.31%	2.8%	5.4%	4.78%	4.24%	2.87%	3.24%	4.66%	9.44%	8.07%	3.97%	3.08%	3.27%
Operating Expenses	$3.949M	$3.707M	$9.214M	$4.441M	$4.480M	$4.599M	$4.660M	$5.875M	$5.703M	$6.110M	$5.760M	$4.130M	$3.410M	$2.790M	$2.920M	$3.130M	$3.180M	$2.230M	$40.00K
YoY Change	6.54%	-59.77%	107.46%	-0.87%	-2.58%	-1.32%	-20.68%	3.01%	-6.66%	6.08%	39.47%	21.11%	22.22%	-4.45%	-6.71%	-1.57%	42.6%	5475.0%
Operating Profit	$1.117M	$1.175M	-$3.854M	$2.226M	$1.697M	$1.088M	-$817.7K	-$91.75K	$1.781M	$2.860M	$6.070M	$5.740M	$3.450M	$600.0K	$920.0K	$2.660M	$3.640M	$3.880M
YoY Change	-4.9%	-130.49%	-273.16%	31.17%	55.91%	-233.09%	791.23%	-105.15%	-37.72%	-52.88%	5.75%	66.38%	475.0%	-34.78%	-65.41%	-26.92%	-6.19%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Interest Expense		$64.15K	$0.00						$11.47K	$0.00	$0.00	$0.00	$10.00K	$10.00K	-$30.00K	-$140.0K	-$280.0K	-$390.0K
YoY Change												-100.0%	0.0%	-133.33%	-78.57%	-50.0%	-28.21%
% of Operating Profit		5.46%							0.64%	0.0%	0.0%	0.0%	0.29%	1.67%	-3.26%	-5.26%	-7.69%	-10.05%
Other Income/Expense, Net	$570.1K	$13.42K	$1.978M	$64.46K	$526.6K	$435.5K	$43.75K	-$56.98K
YoY Change	4148.59%	-99.32%	2967.96%	-87.76%	20.9%	895.5%	-176.78%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Pretax Income	$1.687M	$1.188M	-$1.876M	$2.290M	$2.223M	$1.524M	-$774.0K	-$203.7K	$1.793M	$2.880M	$6.080M	$5.760M	$3.460M	$620.0K	$900.0K	$2.510M	$3.340M	$3.500M	-$20.00K
YoY Change	42.0%	-163.35%	-181.92%	3.0%	45.9%	-296.88%	279.87%	-111.36%	-37.75%	-52.63%	5.56%	66.47%	458.06%	-31.11%	-64.14%	-24.85%	-4.57%	-17600.0%
Income Tax	$377.3K	$181.7K	$213.2K	$239.1K	$136.0K	$85.53K	$3.870K	$52.83K	$168.0K	$460.0K	$1.170M	$1.070M	$300.0K	$250.0K	$360.0K	$1.020M	$1.440M	$1.160M	$0.00
% Of Pretax Income	22.36%	15.29%		10.44%	6.12%	5.61%			9.37%	15.97%	19.24%	18.58%	8.67%	40.32%	40.0%	40.64%	43.11%	33.14%
Net Earnings	$1.310M	$1.007M	-$2.089M	$2.051M	$2.087M	$1.280M	-$1.415M	-$256.6K	$1.625M	$2.410M	$4.910M	$4.690M	$3.160M	$370.0K	$540.0K	$1.490M	$1.900M	$2.340M	-$20.00K
YoY Change	30.15%	-148.18%	-201.87%	-1.74%	63.1%	-190.45%	451.45%	-115.79%	-32.58%	-50.92%	4.69%	48.42%	754.05%	-31.48%	-63.76%	-21.58%	-18.8%	-11800.0%
Net Earnings / Revenue	7.72%	5.19%	-10.39%	9.51%	10.7%	7.19%	-10.64%	-1.31%	6.95%	8.74%	14.85%	16.05%	15.86%	3.26%	4.7%	9.8%	11.72%	16.44%	-200.0%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.06	$0.04	-$90.73K	$89.02K	$90.30K	$55.41K	-$61.25K	-$11.15K	$69.44K	$101.7K	$207.5K	$204.4K	$140.1K	$16.53K	$24.18K	$66.94K	$85.70K	$130.9K	-$74.07K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Cash & Short-Term Investments	$14.98M	$14.46M	$17.47M	$17.14M	$15.49M	$16.07M	$11.62M	$13.79M	$14.93M	$15.16M	$12.12M	$6.630M	$4.410M	$2.410M	$2.050M	$3.090M	$4.790M	$2.280M	$50.00K
YoY Change	3.56%	-17.21%	1.93%	10.64%	-3.63%	38.36%	-15.77%	-7.59%	-1.54%	25.08%	82.81%	50.34%	82.99%	17.56%	-33.66%	-35.49%	110.09%	4460.0%
Cash & Equivalents	$10.45M	$14.46M	$17.47M	$17.14M	$15.49M	$16.03M	$11.59M	$13.77M	$14.89M	$15.09M	$12.05M	$6.540M	$4.320M	$2.320M	$2.050M	$3.090M	$4.790M	$2.280M
Short-Term Investments	$4.531M				$0.00	$44.48K	$26.60K	$20.28K	$33.43K	$70.00K	$70.00K	$100.0K	$100.0K	$100.0K
Other Short-Term Assets	$483.0K	$498.4K	$740.9K	$468.7K	$453.8K	$394.0K	$3.741M	$981.1K	$891.9K	$780.0K	$770.0K	$380.0K	$330.0K	$270.0K	$300.0K	$190.0K	$280.0K	$470.0K
YoY Change	-3.08%	-32.73%	58.07%	3.29%	15.17%	-89.47%	281.3%	10.0%	14.35%	1.3%	102.63%	15.15%	22.22%	-10.0%	57.89%	-32.14%	-40.43%
Inventory
Prepaid Expenses
Receivables	$3.941M	$4.983M	$4.613M	$9.728M	$8.781M	$5.193M	$6.317M	$6.853M	$7.448M	$6.390M	$7.400M	$7.580M	$4.860M	$2.520M	$2.040M	$3.250M	$3.560M	$5.800M	$0.00
Other Receivables	$0.00	$0.00	$0.00	$1.250M	$1.250M	$1.750M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.40M	$19.94M	$22.82M	$28.58M	$25.97M	$23.41M	$21.68M	$21.63M	$23.27M	$22.32M	$20.29M	$14.60M	$9.610M	$5.200M	$4.390M	$6.530M	$8.630M	$8.540M	$50.00K
YoY Change	-2.72%	-12.61%	-20.16%	10.05%	10.95%	8.01%	0.22%	-7.04%	4.24%	10.0%	38.97%	51.93%	84.81%	18.45%	-32.77%	-24.33%	1.05%	16980.0%
Property, Plant & Equipment	$389.3K	$576.4K	$745.5K	$1.064M	$290.7K	$298.0K	$250.6K	$2.334M	$854.0K	$870.0K	$980.0K	$1.110M	$1.220M	$1.320M	$1.570M	$1.520M	$800.0K	$400.0K
YoY Change	-32.46%	-22.69%	-29.95%	266.16%	-2.47%	18.92%	-89.26%	173.32%	-1.84%	-11.22%	-11.71%	-9.02%	-7.58%	-15.92%	3.29%	90.0%	100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$111.7K	$130.9K	$353.4K	$270.2K	$367.4K	$418.5K	$422.9K	$35.58K	$18.26K	$20.00K	$20.00K	$30.00K	$30.00K	$10.00K	$10.00K	$10.00K	$20.00K	$10.00K
YoY Change	-14.67%	-62.96%	30.75%	-26.45%	-12.2%	-1.05%	1088.67%	94.85%	-8.7%	0.0%	-33.33%	0.0%	200.0%	0.0%	0.0%	-50.0%	100.0%
Total Long-Term Assets	$501.0K	$707.3K	$1.099M	$1.335M	$658.1K	$1.967M	$673.5K	$2.370M	$872.2K	$890.0K	$990.0K	$1.140M	$1.240M	$1.360M	$1.630M	$1.580M	$930.0K	$600.0K	$0.00
YoY Change	-29.17%	-35.64%	-17.66%	102.79%	-66.53%	191.97%	-71.58%	171.68%	-2.0%	-10.1%	-13.16%	-8.06%	-8.82%	-16.56%	3.16%	69.89%	55.0%
Total Assets	$19.90M	$20.65M	$23.92M	$29.92M	$26.63M	$25.38M	$22.35M	$24.00M	$24.14M	$23.21M	$21.28M	$15.74M	$10.85M	$6.560M	$6.020M	$8.110M	$9.560M	$9.140M	$50.00K
YoY Change
Accounts Payable	$1.467M	$1.630M	$2.071M	$1.938M	$1.590M	$2.140M	$1.417M	$2.091M	$2.062M	$2.360M	$2.830M	$2.560M	$1.940M	$1.210M	$0.00	$2.710M	$2.710M	$2.710M
YoY Change	-9.95%	-21.32%	6.86%	21.89%	-25.69%	51.06%	-32.24%	1.4%	-12.63%	-16.61%	10.55%	31.96%	60.33%		-100.0%	0.0%	0.0%
Accrued Expenses	$152.5K	$140.9K	$130.1K	$162.9K															$0.00
YoY Change	8.24%	8.3%	-20.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00	$1.299M	$11.03K	$13.77K	$13.95K	$22.95K	$22.78K	$20.00K	$30.00K	$40.00K	$30.00K	$20.00K	$40.00K	$50.00K	$40.00K	$40.00K
YoY Change			-100.0%	11680.96%	-19.9%	-1.29%	-39.22%	0.75%	13.9%	-33.33%	-25.0%	33.33%	50.0%	-50.0%	-20.0%	25.0%	0.0%
Total Short-Term Liabilities	$2.154M	$2.108M	$2.651M	$3.793M	$3.671M	$2.566M	$1.543M	$2.159M	$2.124M	$2.630M	$3.180M	$2.780M	$2.520M	$1.430M	$1.300M	$3.990M	$4.770M	$3.950M	$0.00
YoY Change	2.18%	-20.5%	-30.1%	3.33%	43.06%	66.29%	-28.52%	1.63%	-19.25%	-17.3%	14.39%	10.32%	76.22%	10.0%	-67.42%	-16.35%	20.76%
Long-Term Debt	$0.00	$0.00	$0.00	$699.3K	$67.08K	$46.03K	$59.80K	$29.00K	$51.95K	$70.00K	$50.00K	$80.00K	$90.00K	$50.00K	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change			-100.0%	942.55%	45.73%	-23.03%	106.21%	-44.18%	-25.79%	40.0%	-37.5%	-11.11%	80.0%
Other Long-Term Liabilities	$194.0K	$346.5K	$505.3K	$647.9K	$17.95K	$17.95K	$0.00								$60.00K	$70.00K	$2.630M	$5.040M
YoY Change	-44.0%	-31.43%	-22.01%	3509.64%	0.0%										-14.29%	-97.34%	-47.82%
Total Long-Term Liabilities	$194.0K	$346.5K	$505.3K	$1.347M	$85.03K	$63.98K	$59.80K	$29.00K	$51.95K	$70.00K	$50.00K	$80.00K	$90.00K	$50.00K	$60.00K	$70.00K	$2.630M	$5.040M	$0.00
YoY Change	-44.0%	-31.43%	-62.49%	1484.46%	32.9%	6.99%	106.21%	-44.18%	-25.79%	40.0%	-37.5%	-11.11%	80.0%	-16.67%	-14.29%	-97.34%	-47.82%
Total Liabilities	$3.775M	$4.093M	$5.007M	$7.202M	$6.026M	$5.115M	$1.603M	$2.188M	$2.176M	$2.700M	$3.230M	$2.860M	$2.620M	$1.490M	$1.360M	$4.060M	$7.400M	$8.990M	$0.00
YoY Change	-7.77%	-18.25%	-30.48%	19.53%	17.81%	219.12%	-26.73%	0.54%	-19.41%	-16.41%	12.94%	9.16%	75.84%	9.56%	-66.5%	-45.14%	-17.69%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	22.97M shares	23.00M shares	23.03M shares	23.00M shares
Diluted Shares Outstanding	23.00M shares	23.03M shares	23.16M shares	23.04M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $13.775 Million

About Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. engages in the provision of technical compliance consulting service and microbiological and chemical laboratory testing services to the pharmaceutical, chemical, medical device, and biotechnology industries. The firm operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The firm provides a range of compliance-related consulting services. The firm provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The firm's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The firm markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.

Industry: Services-Management Consulting Services Peers: